Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension

NCT06917131 is registered in ClinicalTrials.gov with Universidade Federal Fluminense as lead sponsor.

NCT NCT06917131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06917131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension
Lead sponsor
Universidade Federal Fluminense
Phase
Not applicable
Overall status
Recruiting
Start date
September 18, 2024
Completion date
December 10, 2026
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases (cvd), hypertension, inflammation